Read more
A distinguished international panel of authors define our current understanding of neuronal damage after ischemia and critically review the significant recent developments and progress in cerebrovascular accident (CVA) drug trials, both in animal models and in the clinical setting. These leading basic and fundamental authorities survey such important new drugs as calcium-influx inhibitors, free-radical scavenging drugs, glutamate and glycinergic antagonists, and immune suppressors. They also evaluate all the latest findings concerning calcium homeostasis, glutamate toxicity, gene activation, and the role of free radicals, glycine, and hormones. Chapters devoted to the neuroimaging of stroke, clinical trials, and the role of cerebral immune activation complete this informative collection of cutting-edge reviews.
List of contents
1 Stroke: Prevalence and Mechanisms of Cell Death.- 2 Imaging of Stroke.- 3 Clinical Aspects of Stroke and Therapeutic Strategies.- 4 Calcium Homeostasis, Nimodipine, and Stroke.- 5 Glutamate Neurotoxicity and Stroke.- 6 Glycine Antagonists for Treatment of Ischemic Brain Injury.- 7 Free Radical-Mediated Cerebral Damage After Hypoxia/Ischemia and Stroke.- 8 Genomic Responses Following Cerebral Ischemia.- 9 Hormonal Modulators of Cerebral Ischemia.- 10 Inflammatory Responses to Cerebral Ischemia: Implications for Stroke Treatment.- 11 Animal Models Used in Cerebral Ischemia and Stroke Research.
Report
". . .the new standard reference work for neurologists and neurosurgeons treating patients with CVA."-Trends in Neuroscience
